Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab

Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab

Bibliographic Details
Main Authors:	Irene Carrión-Barberà, Tarek Carlos Salman-Monte, Sonia Castell, Francisco Castro-Domínguez, Fabiola Ojeda, Jordi Monfort
Format:	Article
Language:	English
Published:	AVES 2019-07-01
Series:	European Journal of Rheumatology
Online Access:	https://www.eurjrheumatol.org/eng/makale/3231/219/Full-Text

Similar Items

Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016-01-01)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus
by: Irene Carrión-Barberà, et al.
Published: (2024-03-01)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
by: Guzman M, et al.
Published: (2020-06-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

PB2616: SYSTEMIC LUPUS ERYTHEMATOSUS RELATED IMMUNE THROMBOCYTOPENIA: A CHARACTERISTIC CLINICAL FENOTIPE
by: Jesus Cornudella, et al.
Published: (2023-08-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab
by: E. L. Nasonov
Published: (2014-12-01)

Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus
by: Lujayn Akbar, et al.
Published: (2020-10-01)

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment
by: Kyriakos A. Kirou, et al.
Published: (2022-08-01)

Belimumab in childhood systemic lupus erythematosus: A review of available data
by: Feng Chen, et al.
Published: (2022-07-01)

Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
by: Irene Carrión-Barberà, et al.
Published: (2024-03-01)

Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
by: Yeo-Jin Lee, et al.
Published: (2024-03-01)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
by: Ioannis Parodis, et al.
Published: (2020-05-01)

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
by: Cevey M, et al.
Published: (2019-12-01)

LP-189 Effect of belimumab in patients with systemic lupus erythematosus treated with minimal or no steroid
by: Ji Seon Oh, et al.
Published: (2023-07-01)

Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
by: Chunye Wu, et al.
Published: (2022-11-01)

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
by: Bangert E, et al.
Published: (2019-01-01)

An update on belimumab for the treatment of lupus
by: Aikaterini Thanou-Stavraki, et al.
Published: (2011-02-01)

PB2613: PREDICTIVE MODEL TO EVALUATE THE RISK OF IMMUNE THROMBOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Jesus Cornudella, et al.
Published: (2023-08-01)

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus
by: Hiroya Hashimoto, et al.
Published: (2023-08-01)

LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients
by: Ruiling Feng
Published: (2023-07-01)

Experience of long-term belimumab use in patients with systemic lupus erythematosus (a case report)
by: Natalia Gennadyevna Klyukvina
Published: (2013-06-01)

Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
by: Hao Cheng, et al.
Published: (2022-08-01)

S01.4 Belimumab disrupts memory B-cell trafficking in patients with systemic lupus erythematosus
by: C van Kooten, et al.
Published: (2022-10-01)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
by: Leanna M. Wise, et al.
Published: (2020-06-01)

Safety of belimumab in association with denosumab in a patient affected by Lupus Erythematosus: a case report
by: Marco Scarati, et al.
Published: (2017-04-01)

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
by: Woori Shin, et al.
Published: (2018-03-01)

Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison
by: Hermine I Brunner, et al.
Published: (2021-11-01)

LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
by: Íñigo Rúa-Figueroa, et al.
Published: (2023-07-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

propósito de un caso de pleuropericarditis purulenta
by: Pedro Visca, et al.
Published: (1982-03-01)

P158 Belimumab for the treatment of systemic lupus erythematosus in the real world: a single center study
by: Jorge Juan Fragío Gil, et al.
Published: (2024-03-01)

Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
by: Tania Colasanti, et al.
Published: (2022-01-01)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
by: Michelle Petri, et al.
Published: (2023-01-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Nick Ballew, et al.
Published: (2022-12-01)